West Pharmaceutical Services Inc
NYSE:WST

Watchlist Manager
West Pharmaceutical Services Inc Logo
West Pharmaceutical Services Inc
NYSE:WST
Watchlist
Price: 271.35 USD -0.44%
Market Cap: 19.5B USD

Intrinsic Value

The intrinsic value of one WST stock under the Base Case scenario is hidden USD. Compared to the current market price of 271.35 USD, West Pharmaceutical Services Inc is hidden .

The Intrinsic Value is calculated as the average of DCF and Relative values:

WST Intrinsic Value
HIDDEN
Show
Worst Case
Base Case
Best Case

Valuation History
West Pharmaceutical Services Inc

Intrinsic Value History
Dive into the past to invest in the future

WST looks overvalued. Yet it might still be cheap by its own standards. Some stocks live permanently above intrinsic value; Historical Valuation reveals whether WST usually does or if today's premium is unusual.

Learn how current stock valuations stack up against historical averages to gauge true investment potential.

Show Historical Valuation
What is Valuation History?
Ask AI Assistant
What other research platforms think about WST?

Let our AI compare Alpha Spread’s intrinsic value with external valuations from Simply Wall St, GuruFocus, ValueInvesting.io, Seeking Alpha, and others.

Discover External Valuations
Why is WST valued this way?

Let our AI break down the key assumptions behind the intrinsic value calculation for West Pharmaceutical Services Inc.

Explain Valuation
Compare WST to

Fundamental Analysis

Company Overview
Loading...
Business Segments
Loading...
Economic Moat
Loading...
Earnings Call
Loading...
Management
Loading...
Contacts
Loading...
Bear Theses

West Pharmaceutical’s concentration in injectable packaging components exposes it heavily to a small number of large pharma customers; significant contract loss or slower orders from these key clients could materially impact revenue growth.

Bull Theses

Strong demand for injectable drug delivery systems, especially amid growth in biologics and biosimilars, positions West Pharmaceutical for sustained volume and margin expansion.

Show More Less
How do you feel about WST?
Bearish
Neutral
Bullish
Financials
Annual
Quarterly
TTM
Annual
Quarterly
TTM

Balance Sheet Decomposition
West Pharmaceutical Services Inc

Current Assets 1.8B
Cash & Short-Term Investments 628.5m
Receivables 652.5m
Other Current Assets 542.3m
Non-Current Assets 2.3B
Long-Term Investments 220.9m
PP&E 1.9B
Intangibles 119.5m
Other Non-Current Assets 68.5m
Current Liabilities 635.4m
Accounts Payable 255.8m
Accrued Liabilities 133.2m
Other Current Liabilities 246.4m
Non-Current Liabilities 418.9m
Long-Term Debt 206.6m
Other Non-Current Liabilities 212.3m
Efficiency

Free Cash Flow Analysis
West Pharmaceutical Services Inc

Last Value
3-Years Average
FCF Margin
Conversion Rate

Earnings Waterfall
West Pharmaceutical Services Inc

Revenue
3B USD
Cost of Revenue
-1.9B USD
Gross Profit
1.1B USD
Operating Expenses
-448.6m USD
Operating Income
625.1m USD
Other Expenses
-133.4m USD
Net Income
491.7m USD
Fundamental Scores

WST Profitability Score
Profitability Due Diligence

West Pharmaceutical Services Inc's profitability score is hidden . The higher the profitability score, the more profitable the company is.

Positive 3Y Average ROIC
Positive 3Y Average ROE
Healthy Operating Margin
Positive ROIC
hidden
Profitability
Score

West Pharmaceutical Services Inc's profitability score is hidden . The higher the profitability score, the more profitable the company is.

WST Solvency Score
Solvency Due Diligence

West Pharmaceutical Services Inc's solvency score is hidden . The higher the solvency score, the more solvent the company is.

High Interest Coverage
High Altman Z-Score
Long-Term Solvency
Low D/E
hidden
Solvency
Score

West Pharmaceutical Services Inc's solvency score is hidden . The higher the solvency score, the more solvent the company is.

Wall St
Price Targets

WST Price Targets Summary
West Pharmaceutical Services Inc

Wall Street analysts forecast WST stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for WST is 349.43 USD with a low forecast of 287.85 USD and a high forecast of 393.75 USD.

Lowest
Price Target
287.85 USD
6% Upside
Average
Price Target
349.43 USD
29% Upside
Highest
Price Target
393.75 USD
45% Upside
View Analyst Estimates
View Analyst Estimates

Dividends

Dividend Yield
Lowest
Average
Highest
Dividend Per Share
Growth 3Y
Growth 5Y
Growth 10Y
Dividend Safety Score
Very
Unsafe
Unsafe
Safe
Very
Safe
0
25
50
75
100
Previous Payment
-
Today
Next Payment
-
Today
Dec 12, 2025
Previous Payment
-
Next Payment
-
Ex-Dividend Date
-
Shareholder Yield

Current shareholder yield for WST is hidden .

Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?

Shareholder Yield
HIDDEN
Show
Dividend Yield
Lowest
Average
Highest
Buyback Yield
HIDDEN
Debt Paydown Yield
HIDDEN

Competitive Landscape

Company Market Cap Intrinsic Valuation Profitability Solvency Price Change
1Y 3Y 5Y

Ownership

WST Insider Trading
Buy and sell transactions by insiders

WST News

Other Videos
What is the Intrinsic Value of one WST stock?

The intrinsic value of one WST stock under the Base Case scenario is hidden USD.

Is WST stock undervalued or overvalued?

Compared to the current market price of 271.35 USD, West Pharmaceutical Services Inc is hidden .

Back to Top